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Abstract Approximately 300 cases of sporadic parathy-
roid cyst (PCs) have been reported to date. Only two cases
have been described in MEN1 so far. Detection by imaging
could be challenging, especially in multiglandular primary
hyperparathyroidism (HPT) and clinical outcome could be
different. During the period 1990–2014, 71 MEN1 patients
were operated for primary hyperparathyroidism in our
centre. We report three cases of PCs in MEN1 patients
affected by HPT, who underwent a total or subtotal
parathyroidectomy with transcervical thymectomy. In our
series, all three patients had an unsatisfactory postoperative
course, at variance with the high percentage (over 90 %) of
long-term success in MEN1 patients operated at our centre.
One patient affected by cystic degeneration of all the four
parathyroid glands reported persistent hypoparathyroidism,
despite autografts of parathyroid tissue. For the other two
cases, surgery failed to cure hyperparathyroidism, perhaps
because of the presence of undetected ectopic parathyroid
tissue. In the context of a multiglandular disease such as
MEN1 syndrome, PCs seem rare but our experience shows
about a 4 % incidence. Furthermore their presence, even in
expert hands, could affect the preoperative identification of
the parathyroid glands due to the difficult differential
diagnosis between PC and other cystic lesions of the neck,
and intraoperative detection of the glands as well as the
postoperative outcome.
Keywords MEN1  HPT  Parathyroid cysts  Surgery 
PTH
Abbreviations
PC Parathyroid cyst
MEN1 Multiple endocrine neoplasia syndrome type 1
HPT Hyperparathyroidism
PTH Parathyroid hormone
IOPTH Intraoperative parathyroid hormone
US Ultrasonography
FNA Fine needle aspiration
MRI Magnetic resonance imaging
SPECT–
CT
Single-photon emission computed
tomography/computed tomography
VIP Vasoactive intestinal peptide
HPT–JT Hyperparathyroidism–jaw tumour syndrome
Introduction
Parathyroid cysts (PCs) were originally described in 1880
by the Swedish anatomist Sandstrom [1], and removed for
the first time by a Belgian surgeon, Goris, in 1905 [2]. Crile
Jr. and Perryman [3] were the first to diagnose PCs using
fine needle aspiration (FNA) in 1953.
PCs are rare lesions, often discovered incidentally dur-
ing neck surgery or imaging procedures. To date, \300
cases of PCs have been documented, accounting for
0.08–3.41 % of all parathyroid lesions [4–6]. McCoy et al.
[7] found cystic parathyroid lesions in 3 % of 1769 patients
undergoing surgery for primary hyperparathyroidism
(HPT). In a retrospective study of 6621 patients submitted
to a neck ultrasonography (US), Cappelli et al. [8] reported
an incidence of 0.075 % in an unselected group. PCs are
more common in the fourth and fifth decades of life [9–11];
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however, several paediatric cases have also been described
[12]. PCs may be functioning or non-functioning. Non-
functioning cysts encompass 90 % of cases and occur more
commonly in females [13, 14]. Functioning cysts usually
affect males and are associated with primary HPT [13].
Clinical presentation of PCs depend on site, size, and
hormonal activity. Although most PCs are orthotopic,
ectopic localization is possible in the cervical region,
including both the thyroid and thymus [15–18]. Mediasti-
nal PCs are usually large (C4 cm), causing compressive
symptoms such as dysphagia and dyspnea [13, 19, 20], at
times mimicking retrosternal goitre [14]. Vocal cord
paralysis due to compression on the recurrent laryngeal
nerve [21–23], respiratory failure and jugular or innomi-
nate vein thrombosis have also been reported as compli-
cations [24]. Haemorrhage is an additional complication,
which causes a rapid increase in volume and adhesion to
surrounding structures, thus suggesting malignancy.
Only two cases of PC have been described in MEN1,
both occurring in Japanese patients [25, 26]. We report
three cases of PC in MEN1 patients, from different fami-
lies, who underwent surgery at our centre (Table 1).
Patients and methods
During the period 1990–2014, 71 MEN1 patients were oper-
ated for primary HPT in our Centre. We report three cases of
PCs in MEN1 patients affected by HPT, who underwent a total
or subtotal parathyroidectomy with transcervical thymec-
tomy. Histology confirmed the presence of PC in all patients
(Fig. 1). Written informed consent was obtained from all the
study participants, obtaining ethical approval from the local
Experts Committee of Careggi Hospital.
Case 1
A 46-year-old man was diagnosed with primary HPT in
MEN1 syndrome (gene mutation: c.1522C[ T exon 10).
Neck US did not detect any parathyroid lesion, while
MIBI scintigraphy revealed an increased uptake at the left
lower pole of the thyroid. The patient initially refused
surgery but, due to his high serum calcium levels, was
given the calcimimetic agent cinacalcet. Three months
later, he underwent total parathyroidectomy and thymec-
tomy with intraoperative parathyroid hormone (IOPTH)
monitoring. After mobilization of the thyroid lobes, pos-
terior to the right inferior thyroid artery, an upper
parathyroid gland (30 9 19 9 16 mm) of cystic appear-
ance was found. The right lower gland, located within the
thyroid capsule, appeared normal (5 9 3 9 2 mm) and
was left in place until the end of surgery to preserve its
vascularisation for subsequent autotransplantation. On the
left side, the upper parathyroid gland measured
23 9 11 9 8 mm and the lower gland 9 9 6 9 5 mm.
The thymus and thyro-thymic ligament were then
removed en-bloc. Ten minutes after clamping the right
lower parathyroid gland, PTH levels progressively drop-
ped, falling to values at the limits of measurability
(Fig. 2). Ten submillimetric fragments from this gland
were grafted in the non-dominant forearm and several
tissue fragments were also cryopreserved. Histology
showed chief cell hyperplasia in the four parathyroid
glands, all cystic in appearance. The parathyroid tissue
diffusely stained for parafibromin.
In the postoperative course, hypoparathyroidism occur-
red, requiring calcium and vitamin D supplements.
After 3 months, the patient was subjected to a spleen-
preserving distal pancreatectomy and cholecystectomy.
Pathological examination revealed endocrine multihor-
monal microadenomatosis of the pancreas. There was no
evidence of lymph node metastasis.
Eight months after neck surgery, persistent hypocal-
cemia required autotransplantation of the cryopreserved
parathyroid tissue and approximately 30 fragments were
inserted into the fibres of the brachioradialis muscle.
However, calcium and PTH levels did not normalize and
the patient is currently taking calcium and calcitriol tablets.
Table 1 Clinico-pathological features of MEN1 associated PC
Case US Scintigraphy/MRI No. glands
detected
at surgery
No. cystic
glands
Preoperative
therapy (Cinacalcet)
(months)
Outcome
1 (#, 46) 0 1 4 4 1 Hypoparathyroidism
2 ($, 30) 2
Polylobulated, calcific
0
MRI negative for
neck or mediastinal
lesions
3 1 8 Hyperparathyroidism
3 (#, 62) 3 (?1?)
Rich vascularization
2 4 1 25 Normal calcemia, mild
elevation of PTH
T. Cavalli et al.
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Case 2
HPT was diagnosed in a 30-year-old woman affected with
MEN1 syndrome (gene mutation: frameshift 613delT, exon
3). Frequent hypoglycaemic crises due to pancreatic
insulinoma required prompt surgical treatment and she
received cinacalcet for 8 months to control her hypercal-
cemia before undergoing parathyroidectomy. Neck US
demonstrated a small, slightly hypoechoic nodule with
smooth contours, measuring 4 9 3 9 2 mm, in the left
thyroid lobe. A hypoechoic polycystic lesion, measuring
7 9 6 9 15 mm and exhibiting small calcifications, was
identified caudal to the right thyroid lobe. Two anechoic
nodules of 6 and 5 mm were also seen below the left
thyroid lobe. On a subsequent thyroid US, two formations
compatible with parathyroid glands were found at the
upper pole of the right lobe and at the lower pole of the left
lobe, 11.8 and 4.6 mm respectively.
After 8 months of medical therapy, the patient underwent
bilateral neck exploration and thymectomy. At surgery, both
the upper glands were increased in volume: the left one
measured 25 9 10 9 5 mm; the right one, 15 9 9 9 5 mm,
sited at the dihedral angle between the inferior thyroid artery
and the laryngeal nerve, was adherent to the ipsilateral
recurrent nerve. A 5-mm nodule, attached to the inferior right
thyroid pole, was detected and removed. One hour after the
final parathyroidectomy, PTH was half the manipulation
value although it did not reach undetectable levels (Fig. 2). No
further glands were found. Histology revealed chief cell
hyperplasia in the three orthotopic glands removed, whereas
the 5-mm nodule attached to the right lower thyroid pole was
diagnosed as a cystic parathyroid gland. Immunostain for
parafibromin resulted positive.
Persistent HPT after surgery required treatment with
cinacalcet (Table 2).
Case 3
A 62-year-old man, operated for a pancreatic VIPoma
metastatic to the liver, was diagnosed with MEN1 syn-
drome (gene mutation: frameshift 67ins5 bp, exon 2). He
received cinacalcet for 25 months for severe HPT before
undergoing total parathyroidectomy and thymectomy.
Preoperative neck magnetic resonance imaging (MRI)
without contrast medium revealed a 3.5 mm subfascial
lipoma in the posterior aspect of the cervical spine. A
hybrid single-photon emission computed tomogra-
phy/computed tomography (SPECT–CT) showed enhanced
Fig. 1 Histology was consistent with PC (H&E, original magnification, 910) for all patients (a = case 1, b = case 2, c = case 3)
Fig. 2 IOPTH decay curves from first gland ‘‘manipulation’’. At the
end of procedure, PTH was almost unmeasurable in patient 1 (P1),
while in P2 and P3, PTH dropped variably below ‘‘manipulation’’
value without reaching unmeasurable values. Continuous curve
represents the bi-exponential PTH decay curve typical of sporadic
primary HPT
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signals both in the mid third of the left thyroid lobe and
below the lower pole.
Bilateral neck exploration demonstrated a cystic right
upper parathyroid gland (39 9 25 9 20 mm), adherent to the
homolateral thyroid lobe, which was then removed. Close to
the left upper pole two ‘‘kissing’’ parathyroid glands mea-
suring 23 9 19 9 12 mm and 24 9 10 9 6 mm were
excised. After the removal of the left lower gland (13 9 12 9
10 mm) sited below the thyroid lower pole, PTH dropped to
normal but did not reach unmeasurable values (Fig. 2). Con-
sequently, a portion of the left inferior parathyroid was cry-
opreserved but no autograft was performed. No further
parathyroid glands were found on cervical exploration.
Histology revealed nodular chief cell hyperplasia with
dystrophic calcifications in the large cystic gland. Parafi-
bromin was strongly expressed and the proliferation index
(Ki-67) was\ 1 % (Fig. 3). The remaining three glands
showed diffuse chief cell hyperplasia. On follow-up, the
patient was normocalcemic, but PTH levels started to rise
3 months after surgery.
Discussion
We present three new cases of PC in MEN1 patients
highlighting their clinical heterogeneous clinical manifes-
tations. Only two cases of PC in MEN1 have been previ-
ously described. In the report by Tamiya et al. [25] a large
cystic lesion (6500 mg) in the context of multinodular
goiter was histologically diagnosed as a PC, while the other
three parathyroid glands were found to be hyperplastic; all
laboratory data returned to normal after parathyroidectomy.
The other case by Kinoshita et al. [26] concerns a MEN1
patient affected by pituitary adenoma, Zollinger-Ellison
syndrome and HPT with a large PC, but clinical informa-
tion is available only in Japanese.
Interestingly, analyzing our data about parathyroid sur-
gery in 71 MEN1 patients, we can estimate an incidence of
4.2 % of patients affected by PC.
PC pathogenesis is still unclear. Non-functiong PCs
may originate as remnants of the third or fourth branchial
cleft [10]. Histologically, the wall of these cysts often
contains fragments of salivary, adipose or thymic tissue,
providing further evidence for this hypothesis. Alterna-
tively, they may derive from the coalescence of micro-
cysts [10]. Recent studies suggest that functioning PCs
may represent cystic degeneration of a pre-existing
parathyroid adenoma or, rarely, a carcinoma [27–29]. In
HPT–jaw tumour syndrome (HPT–JT), patients generally
present one or two parathyroid adenomas, often with
cystic features, and bear a significantly increased risk of
parathyroid carcinoma. Inactivating germ-line HRPT2
(OMIM 145001, region 1q25) mutations have been
reported in kindred with HPT–JT, as well as in familial
isolated primary HPT [30–36]. The HRPT2 gene is
expressed in several human tissues including parathyroid,
bone and kidney [31]. It encodes parafibromin, a
531-amino acid protein belonging to human Paf1 com-
plex, involved in cell proliferation, transcription regula-
tion and histone modification with tumour-suppressor
properties [37, 38]. The majority of sporadic parathyroid
carcinomas harbour germ-line and/or somatic-type HRPT2
mutations, with loss of parafibromin immunoreactivity
[33, 35, 39, 40]. While somatic MEN1 mutations are
common even in sporadic parathyroid adenomas, somatic
HRPT2 mutations have only been reported in four out of
the 137 adenomas studied to date, all with cystic features
[31, 33, 35, 41]. These findings suggest that HRPT2 may
participate in the pathogenesis of parathyroid carcinoma
[42], but also of benign parathyroid tumours with cystic
changes. However, in our three cases of PC in MEN1,
parafibromin was normally expressed.
Table 2 Patient preoperative and postoperative PTH and calcium values
Biochemical analysis Patient 1
#, 46
Patient 2
$, 30
Patient 3
#, 62
Calcemia (mg/dL) (n.r. = 8.2–10.7)
Preop 11.7 (11.8 pre-Ca) 10.0 (11.3 pre-Ca) 10.6 (11.4 pre-Ca)
Postop 7.9 10.2 9.0
Ionized calcium (mg/dL) (n.r. = 4.3–5.3)
Preop 5.6 5.2 5.4
Postop 4.1 5.4 4.5
PTH (pmol/L) (n.r. = 1.3–7.6)
Preop 11.9 9.0 55.6
Postop 1.1 9.5 9.0
n.r. normal range
a pre-C = before starting Cinacalcet
T. Cavalli et al.
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Radiological diagnosis of PCs can be challenging. Neck
US is a valuable tool to distinguish PCs from thyroid or
other cystic masses such as thymic, thyreoglossal duct,
branchial cleft cysts or lymphangioma [43, 44]. However,
in our series, neck US did not show an high sensitivity for
PC: for example in the first case, even in the presence of
two large glands (about 2.5 cm in diameter) the radiologist
was not able to assess the parathyroideal nature of the
cystic lesions. Radio-nucleotide scans usually reveal areas
with decreased or no uptake, thus mimicking cold nodules.
Technetium-99 m sestamibi imaging may furnish equivo-
cal results, even in functioning PCs [45]. CT and MRI
findings are nonspecific, and PCs may be difficult to dif-
ferentiate from other cystic lesions located in the lower
neck or in the superior mediastinum. However, a PC should
be considered when radiological images demonstrate a
cystic lesion posterior to the thyroid, with an extension to
the superior mediastinum [46].
FNA is a valid diagnostic tool. Watery, colourless
crystal clear fluid suggests non-functioning PC, although a
coloured aspirate does not exclude this entity [47]. Func-
tioning PCs may hold a yellow or brown aspirate as a result
of degeneration of a parathyroid adenoma containing
hemosiderin. Diagnosis can be established by elevated
PTH levels in the aspiration fluid [48]. PTH concentration
in the cystic fluid of non-functioning PCs ranges from
several hundred to over 400,000 pg/ml with normal serum
PTH levels [49]. Thyroid cysts usually yield a yellowish or
bloody aspirate with high thyroglobulin and unde-
tectable PTH levels,whereas a yellowish and viscous
aspirate is characteristic of branchial cysts [50].
Grossly, PCs may measure up to 10 cm in diameter and are
almost always unilocular. On microscopic examination, non-
functioning PCs exhibit a smooth inner surface wall with an
epithelial lining consisting of a single layer of cuboidal or
columnar cells staining positive for glycogen [51].
Taking into account the size of the cyst, standard
treatment of uncomplicated non-functioning PCs is percu-
taneous aspiration, first described by Clark [29]. Surgical
excision is the gold standard for functioning PC and non-
functioning PC with compressive symptoms [52].
IOPTH monitoring could be useful to assess surgical
outcome, but in PC it can be misleading if the cyst is
ruptured and in MEN1 cases it can provide false positive
results: in our case 1, after removal of the first parathyroid
gland, the PTH decay followed the bi-exponential curve
typical of sporadic primary HPT (continuous curve in
Fig. 2) as we described in a previous paper [53]. Therefore,
in MEN1 we believe that IOPTH is useful only to assess
the absence of residual parathyroid tissue after total
parathyroidectomy, revealing extremely low, almost
unmeasurable serum PTH values.
Calcium levels should be checked postoperatively since
hypocalcemia has been reported after successful removal
Fig. 3 a Large PC with thickened fibrous wall. b The parathyroid tissue was intensely reactive for parathyroid hormone. c Nuclear parafibromin
staining was retained (original magnifications, 9400)
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of predominantly larger hyperfunctioning cysts (especially
lesions weighing 4 grams or more; p = 0.03) [7].
In our series, all three patients received cinacalcet before
parathyroidectomy (60 mg daily). The postoperative
course was unsatisfactory in all cases (Table 1), at variance
with the high percentage (over 90 %) of recurrence-free
rate at more than 10 years follow-up in MEN1 patients
operated at our centre.
Cinacalcet hydrochloride has been approved for the
treatment of hypercalcemia in patients with parathyroid
carcinoma and in primary HPT patients unable to undergo
surgery [54]. Three separate studies have reported its
effectiveness in 11 MEN1 patients [54–56]. Cinacalcet is
also the only available potent calcimimetic for the man-
agement of secondary HPT [57]. No obvious adverse
effects of calcimimetic agents have been noted in patients
undergoing parathyroidectomy for HPT.
During neck surgery for parathyroid hyperplasia, cystic
degeneration can modify gland architecture or mimic
fusion of two glands, leading to a higher risk of under-
treatment. In our series, surgical failure suggests that
parathyroid adenomas with cystic degeneration may exhi-
bit a moderate endocrine activity compared with usual
hyperplastic or adenomatous glands. Their behaviour
resembles that of a normal parathyroid gland, possibly
suppressed by the hormone produced by other adenomas,
as in patient 2, who had a small supernumerary intrathyroid
cystic gland.
Patient 1, who had four cystic hyperplastic glands,
presented postoperative hypoparathyroidism after the fail-
ure of parathyroid tissue grafts, in spite of the attention that
the surgical team paid to avoid pre-graft gland ischaemia,
which lasted about 15 min. The subsequent graft of further
frozen parathyroid tissue was not efficacious to provide a
correct calcemia. Patient 3, who was affected by parathy-
roid hyperplasia with an intrathyroid cystic gland, and
showed mildly elevated PTH levels at 3 months’ follow up,
might have had a fifth gland, which neither instrumental
examination nor surgical exploration discovered after the
removal of the other glands.
In recurrent cases, the injection of sclerosing agents (e.g.
tetracycline solution, ethanol) into the cyst entails the risk
of fibrosis and recurrent laryngeal nerve palsy, especially
when the inferior parathyroid is involved [58, 59].
Conclusions
PCs are uncommon findings in clinical practice. The vast
majority are non-functioning and asymptomatic. Their
identification can be challenging as they can be confused
with thyroid lesions. FNA is useful for diagnosis and initial
treatment of non-functioning cysts. Surgical excision is
recommended in the case of HPT, or when relapse and
compressive symptoms occur. In the context of a
multiglandular disease such as MEN1 syndrome, PCs seem
rare but our experience shows about a 4 % incidence.
Furthermore their presence, even in expert hands, could
affect pre- and intraoperative detection of the glands as
well as the postoperative outcome.
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